Buscar en
Porto Biomedical Journal
Toda la web
Inicio Porto Biomedical Journal Paclitaxel-induced neuropathic pain: Unravelling the underlying mechanisms at th...
Journal Information
Vol. 2. Issue 5.
Pages 192 (September - October 2017)
Share
Share
Download PDF
More article options
Vol. 2. Issue 5.
Pages 192 (September - October 2017)
PS141
Open Access
Paclitaxel-induced neuropathic pain: Unravelling the underlying mechanisms at the central nervous system
Visits
2611
J. Ribeiro1,2,3,
Corresponding author
jribeiro504@gmail.com

Corresponding author.
, J.T. Costa-Pereira1,2,3, I. Tavares1,2,3, I. Martins1,2,3
1 Departamento de Biomedicina – Unidade de Biologia Experimental, Faculdade de Medicina da Universidade do Porto, Portugal
2 i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal
3 IBMC - Instituto de Biologia Celular e Molecular, Universidade do Porto, Portugal
This item has received

Under a Creative Commons license
Article information
Full Text

Aim: Here we studied the effects of the cytostatic paclitaxel on: (i) the development of nociceptive and aversive behaviors; (ii) noxious-evoked-activation of spinal dorsal horn neurons and (iii) on descending noradrenergic modulation, which is the main spinal nociceptive inhibitory system.

Introduction: Chemotherapeutic drugs are widely used for cancer treatment but they also cause numerous deleterious side effects. Chemotherapy-induced neuropathy (CIN) is one of the most common side effects. The mechanisms underlying CIN are starting to be uncovered namely the alterations induced by cytostatics at the peripheral nervous system but the effects of these drugs at the central nervous system are still poorly studied.

Methods: Male Wistar rats were injected with paclitaxel (Taxol, 2.0mg/kg) or the vehicle solution dimethyl sulfoxide on four alternate days. Nociceptive and aversive behaviors were assessed by the von Frey and conditioned place aversion (CPA) tests, respectively. Noxious-evoked-activation of spinal dorsal neurons was achieved at one month after CIN by evaluating the expression of c-fos expression upon cold stimulation. To study the descending noradrenergic pain modulation we assessed the effects of the α2-adrenoreceptor agonist clonidine at 1 and 10μg administered intrathecally, on the von Frey test. We further assessed the expression of the α2-adrenoreceptor and dopamine-β-hydroxylase (DBH), a noradrenaline biosynthetic enzyme expressed in noradrenergic fibers, at the spinal dorsal horn.

Results: Paclitaxel induced mechanical allodynia and aversive behaviors. c-fos and DBH expression were increased in paclitaxel-treated animals while α2-adrenoreceptor expression remained unaltered. Clonidine induced antinociception at both doses with more pronounced effects in paclitaxel-treated animals.

Conclusion: Paclitaxel-treated animals showed neuropathic like-behaviors and increased spinal neuronal activation. It remains to ascertain if DHB upregulation results in increased spinal noradrenaline levels, but the increase of α2-AR antinociceptive potency in paclitaxel-treated animals indicates the recruitment of descending inhibition probably as a buffer to increased spinal sensitization.

Acknowledgements: Funding: Norte 2020 refs: NORTE-01-0145-FEDER-000008.

Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos